Whitepaper
29 Jun 2023

Supporting Small and emerging pharma through collaboration and specialized expertise

PDF 97 kB

Growth in the pharmaceutical industry is no longer exclusively driven by large pharmaceutical companies. The switch in the marketplace from a focus on blockbuster drugs to an emphasis on therapies that treat orphan and rare diseases has led to the rise of small and emerging pharma companies founded to advance novel medicines for specialized patient populations. These innovators require the support of contract service providers that recognize their unique requirements.

Content provided by our supplier

Grifols International, S.A.

  • ES
  • 2015
    On CPHI since
  • 4
    Certificates
  • 5000+
    Employees
Company types
CMO/CDMO
Contract Service
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis

Other Content from Grifols International, S.A. (6)